MUSOLINO, Caterina
 Distribuzione geografica
Continente #
EU - Europa 12.405
NA - Nord America 10.953
AS - Asia 6.289
SA - Sud America 2.388
AF - Africa 219
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 7
Totale 32.277
Nazione #
US - Stati Uniti d'America 10.687
RU - Federazione Russa 6.250
SG - Singapore 2.788
BR - Brasile 2.074
CN - Cina 1.667
IE - Irlanda 1.519
SE - Svezia 1.273
IT - Italia 843
HK - Hong Kong 706
DE - Germania 532
FR - Francia 417
UA - Ucraina 385
VN - Vietnam 362
FI - Finlandia 279
GB - Regno Unito 279
PL - Polonia 241
IN - India 157
CA - Canada 115
AR - Argentina 114
BD - Bangladesh 97
MX - Messico 83
TR - Turchia 72
ZA - Sudafrica 66
AT - Austria 60
HU - Ungheria 60
ID - Indonesia 59
BE - Belgio 58
EC - Ecuador 58
NL - Olanda 55
IQ - Iraq 52
ES - Italia 45
JP - Giappone 43
CO - Colombia 39
MA - Marocco 37
PK - Pakistan 36
UZ - Uzbekistan 34
KE - Kenya 30
VE - Venezuela 26
TN - Tunisia 25
EG - Egitto 22
PY - Paraguay 21
IR - Iran 19
CL - Cile 17
CZ - Repubblica Ceca 17
PH - Filippine 17
AE - Emirati Arabi Uniti 16
BO - Bolivia 15
HN - Honduras 14
LT - Lituania 14
SA - Arabia Saudita 14
DO - Repubblica Dominicana 13
JM - Giamaica 13
JO - Giordania 13
AZ - Azerbaigian 12
IL - Israele 12
KR - Corea 11
UY - Uruguay 11
GR - Grecia 10
NP - Nepal 10
PE - Perù 10
AU - Australia 9
KG - Kirghizistan 9
MY - Malesia 9
OM - Oman 9
PS - Palestinian Territory 9
RO - Romania 9
CR - Costa Rica 8
NO - Norvegia 8
BG - Bulgaria 7
LB - Libano 7
SN - Senegal 7
AL - Albania 6
AO - Angola 6
CH - Svizzera 6
DK - Danimarca 6
KZ - Kazakistan 6
LV - Lettonia 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
SY - Repubblica araba siriana 6
TW - Taiwan 6
CI - Costa d'Avorio 5
GE - Georgia 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
DZ - Algeria 4
ET - Etiopia 4
EU - Europa 4
PA - Panama 4
RS - Serbia 4
AM - Armenia 3
BH - Bahrain 3
KW - Kuwait 3
LY - Libia 3
PR - Porto Rico 3
XK - ???statistics.table.value.countryCode.XK??? 3
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
GH - Ghana 2
Totale 32.241
Città #
Moscow 1.902
Ashburn 1.774
Dublin 1.518
Singapore 1.499
Chandler 1.272
Dallas 1.039
Jacksonville 801
Nyköping 727
Hong Kong 706
Beijing 584
San Jose 494
Messina 352
The Dalles 345
Princeton 279
Dearborn 268
Medford 258
Lauterbourg 249
Los Angeles 242
Warsaw 219
Des Moines 214
Cambridge 209
Ann Arbor 185
São Paulo 181
New York 169
Boardman 139
Munich 126
Buffalo 114
Ho Chi Minh City 105
Council Bluffs 88
Tianjin 88
Hanoi 82
Woodbridge 77
Redondo Beach 74
Frankfurt am Main 71
Wilmington 65
Rio de Janeiro 64
Belo Horizonte 63
Budapest 59
Brussels 57
Guangzhou 57
San Mateo 56
Jinan 51
Vienna 50
Santa Clara 49
Johannesburg 43
Brasília 42
Orem 42
Turku 42
Nanjing 41
Shenyang 41
Tokyo 41
Montreal 40
Chennai 39
Houston 39
Seattle 37
Hebei 36
Lancaster 36
Milan 35
Porto Alegre 34
Brooklyn 33
Helsinki 33
Pune 33
Shanghai 33
Bremen 32
London 32
Atlanta 31
Nuremberg 31
Hangzhou 28
Jakarta 28
Tashkent 28
Curitiba 27
Denver 27
Dong Ket 27
Quito 27
Stockholm 27
Zhengzhou 27
Amsterdam 26
Nairobi 26
Rome 26
San Francisco 25
Poplar 23
Strasbourg 23
Boston 21
Chicago 21
Guarulhos 21
Ningbo 20
Palermo 20
Ribeirão Preto 20
Toronto 19
Campinas 18
Düsseldorf 18
Haikou 18
Manchester 18
Recife 18
Salvador 18
Shenzhen 17
Istanbul 16
Lahore 16
Mexico City 16
Baghdad 15
Totale 18.592
Nome #
Altered Microrna Expression Profile in the peripheral Lymphomonocytes of Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw 299
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 253
A multivariate analysis of Multiple Myeloma subtype plasma cells 248
A micro-Raman spectroscopic investigation of leukemic U-937 cells in aged cultures 243
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 241
Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 234
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws 212
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura 209
E rosette formation in B cell chronic lymphocytic leukemia. 202
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies 201
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 199
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells 198
Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombocythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders 197
Comportamento di alcuni indici della fibrinolisi in dislipidemici in corso di trattamento con sinfibrato" 196
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways 195
Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient. 194
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 193
Aggregazione piastrinica in dislipidemici in corso di trattamento con simfibrato 191
Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma 191
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). 190
A rare spinal localization of gray zone lymphoma without mediastinal involvement: A case report and review of literature 189
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies 188
Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs. 187
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 186
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and n two relatives with lymphoproliferative disorders 183
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors 182
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. 182
Efficacia della chemioterapia convenzionale ad alte dosi in un caso di mieloma multiplo IgM primitivamente doppio-refrattario ai nuovi farmaci 182
Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19 181
Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines 178
Risk stratification and early cardiotoxicity identification: organizational advantages and clinical impact of intrahospital cardiotoxicity network 178
Anxiety, Depression, Distress, and Resilience in Patients with Haematological Malignancies. The Effect of Nine Weeks of Psychological Support on Psychological Status and Stress Biological Markers 178
Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates 177
Cutaneous adverse reactions to lenalidomide. 174
Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia. 174
L'ipersplenismo: attualità e prospettive future 172
ABERRANT EXPRESSION OF CANCER TESTIS ANTIGENS IN HEMATOLOGIC MALIGNANCIES 172
Changes in serum interleukin-8 and sRAGE levels in multiple myeloma patients 172
Vaccination of multiple myeloma: Current strategies and future prospects 171
Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw. 169
Angiogenesis in patients with biphosphonate-associated osteonecrosis of the jaw 168
Assenza della mutazione JAK2 V617F nel compartimento linfoide di un paziente affetto da trombocitemia essenziale e leucemia linfatica cronica a cellule B ed in due parenti affetti da disordini linfoproliferativi 168
Beta 2 microglobulina ed emopatie maligne 168
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 166
Telomerase and telomere biology in hematological diseases: A new therapeutic target 164
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma 163
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 161
Circulating endothelial progenitor cells and angiogenic serum factors in patients with chronic myeloproliferative diseases 159
Global cardiovascular assessment in patients with PH+ chronic myeloid leukaemia treated with TKI: long-term follow-up 159
[Calcium and endocrine pancreas secretion. II. Effects of an infusion of calcium on insulin and glucagon secretion induced by intravenous administration of glucose]. 158
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 157
Serum levels of interleukin-16 in lymphoid malignancies. 157
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients 157
Low-energy laser irradiation promotes cellular damage in glucocorticoid-resistant multiple myeloma cells. 156
Phage-AgNPs complex as SERS probe for U937 cell identification 156
ARA-C a basse dosi nelle sindrome mielodisplastiche in differenti stati evolutivi 155
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 155
Cancer and sars-cov-2 infection: Diagnostic and therapeutic challenges 155
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 154
Carbonyl groups serum levels are associated with CD38 expression in patients with B chronic lymphocytic leucemia. 154
Vaccination strategies in lymphoproliferative disorders: Failures and successes 153
Curcumin Ameliorates the In Vitro Efficacy of Carfilzomib in Human Multiple Myeloma U266 Cells Targeting p53 and NF-κB Pathways. 153
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 153
MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma 152
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab. 151
Standardisation of minimal residual disease in multiple myeloma 151
Anticancer activity of rosmarinus officinalis L.: Mechanisms of action and therapeutic potentials 151
The cancer stem cell hypothesis: a guide to potential molecular targets. 150
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 150
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients. 149
Allergy and risk of hematologic malignancies: Associations and mechanisms. 149
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 149
FITC-labelled clone from phage display for direct detection of leukemia cells in blood 149
Immunohistochemical evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. 148
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 148
Antiproliferative effects of st. John’s wort, its derivatives, and other hypericum species in hematologic malignancies 146
Possible role of Interleuki-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity 144
Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia 143
How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma 143
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. 142
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 Iymphocytes in patients with poIycythemia vera and essential thrombocythemia. 142
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 140
Cardiac involvement in patients with hematologic malignancies. 138
Role of the microbiota in hematologic malignancies. 138
The metabolomic signature of hematologic malignancies 137
Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients 136
Antitumorigenic action of nelfinavir: Effects on multiple myeloma and hematologic malignancies (Review) 136
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 135
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells 135
Effetti di uno stress fisico sulla funzione pistrinica e su alcuni parametri emocoagulativi e della fibrinolisi 134
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. 133
Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock 133
Castleman–Kojima disease (TAFRO syndrome) in a Caucasian patient: A rare case report and review of the literature 133
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies 133
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy. 132
Oxidative stress in oncohematologic diseases: an update. 132
Immunohistochemical evaluation of sarcoglycans and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 130
The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention 129
Raman spectroscopy is able to discriminate between CD138-/CD138+ plasmacells of multiple myeloma patients. 128
SERUM LEVELS OF 2', 5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON THERAPY IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC- LEUKEMIA 126
Totale 16.705
Categoria #
all - tutte 112.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 0 0 0 0 0 0 0 0 100
2021/20221.637 16 118 24 73 54 23 101 65 54 225 222 662
2022/20234.587 409 392 215 409 312 466 53 231 1.862 27 146 65
2023/20241.087 100 197 70 85 98 247 26 71 11 27 16 139
2024/20255.537 136 85 99 337 304 143 91 1.253 1.479 316 463 831
2025/202615.347 702 1.031 1.190 1.087 1.338 3.266 1.892 1.842 1.867 609 252 271
Totale 32.708